Literature DB >> 18278981

Exercise and brain health--implications for multiple sclerosis: Part II--immune factors and stress hormones.

Lesley J White1, Vanessa Castellano.   

Abstract

Part I of this review addressed the possible modulatory role of exercise on neuronal growth factors to promote brain health in neurodegenerative diseases such as multiple sclerosis (MS), which is characterized by varied patterns of inflammation, demyelination and axonal loss. Part II presents evidence that supports the potential neuroprotective effect of exercise on the modulation of immune factors and stress hormones in MS. Many current therapies used to attenuate MS progression are mediated, at least in part, through alterations in the relative concentrations of pro- and anti-inflammatory cytokines. Exercise-induced alterations in local and systemic cytokine production may also benefit immune function in health and disease. Exercise immunomodulation appears to be mediated by a complex interaction of hormones, cytokines and neural factors that may favorably influence immune variables in MS. The promising interplay between exercise and brain health in MS deserves further investigation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18278981     DOI: 10.2165/00007256-200838030-00001

Source DB:  PubMed          Journal:  Sports Med        ISSN: 0112-1642            Impact factor:   11.136


  87 in total

Review 1.  Peroxisome proliferator-activated receptors: nuclear control of metabolism.

Authors:  B Desvergne; W Wahli
Journal:  Endocr Rev       Date:  1999-10       Impact factor: 19.871

Review 2.  Immune-neuro-endocrine interactions: facts and hypotheses.

Authors:  H O Besedovsky; A del Rey
Journal:  Endocr Rev       Date:  1996-02       Impact factor: 19.871

Review 3.  Impact of physical activity and sport on the immune system.

Authors:  R J Shepard; P N Shek
Journal:  Rev Environ Health       Date:  1996 Jul-Sep       Impact factor: 3.458

4.  Cutting edge: clonally restricted production of the neurotrophins brain-derived neurotrophic factor and neurotrophin-3 mRNA by human immune cells and Th1/Th2-polarized expression of their receptors.

Authors:  M Besser; R Wank
Journal:  J Immunol       Date:  1999-06-01       Impact factor: 5.422

5.  Symptomatic lumbar epidural varices. Report of two cases.

Authors:  G A Zimmerman; K Weingarten; M H Lavyne
Journal:  J Neurosurg       Date:  1994-05       Impact factor: 5.115

6.  Long-term exercise and atherogenic activity of blood mononuclear cells in persons at risk of developing ischemic heart disease.

Authors:  J K Smith; R Dykes; J E Douglas; G Krishnaswamy; S Berk
Journal:  JAMA       Date:  1999-05-12       Impact factor: 56.272

7.  Quantitative assessment of motor fatigue and strength in MS.

Authors:  S R Schwid; C A Thornton; S Pandya; K L Manzur; M Sanjak; M D Petrie; M P McDermott; A D Goodman
Journal:  Neurology       Date:  1999-09-11       Impact factor: 9.910

Review 8.  The role of interleukin-10 in autoimmune disease: systemic lupus erythematosus (SLE) and multiple sclerosis (MS).

Authors:  Amy M Beebe; Daniel J Cua; Rene de Waal Malefyt
Journal:  Cytokine Growth Factor Rev       Date:  2002 Aug-Oct       Impact factor: 7.638

Review 9.  Stress hormones, proinflammatory and antiinflammatory cytokines, and autoimmunity.

Authors:  Ilia J Elenkov; George P Chrousos
Journal:  Ann N Y Acad Sci       Date:  2002-06       Impact factor: 5.691

10.  Human nerve growth factor protects common marmosets against autoimmune encephalomyelitis by switching the balance of T helper cell type 1 and 2 cytokines within the central nervous system.

Authors:  P Villoslada; S L Hauser; I Bartke; J Unger; N Heald; D Rosenberg; S W Cheung; W C Mobley; S Fisher; C P Genain
Journal:  J Exp Med       Date:  2000-05-15       Impact factor: 14.307

View more
  18 in total

Review 1.  Physical activity and cognitive function in adults with multiple sclerosis: an integrative review.

Authors:  Janet D Morrison; Lori Mayer
Journal:  Disabil Rehabil       Date:  2016-10-20       Impact factor: 3.033

2.  Exercise and disease progression in multiple sclerosis: can exercise slow down the progression of multiple sclerosis?

Authors:  Ulrik Dalgas; Egon Stenager
Journal:  Ther Adv Neurol Disord       Date:  2012-03       Impact factor: 6.570

Review 3.  Effect of exercise training on chronic inflammation.

Authors:  Kristen M Beavers; Tina E Brinkley; Barbara J Nicklas
Journal:  Clin Chim Acta       Date:  2010-02-25       Impact factor: 3.786

Review 4.  Exercise as Medicine in Multiple Sclerosis-Time for a Paradigm Shift: Preventive, Symptomatic, and Disease-Modifying Aspects and Perspectives.

Authors:  Ulrik Dalgas; Martin Langeskov-Christensen; Egon Stenager; Morten Riemenschneider; Lars G Hvid
Journal:  Curr Neurol Neurosci Rep       Date:  2019-11-13       Impact factor: 5.081

Review 5.  Effects of exercise in experimental autoimmune encephalomyelitis (an animal model of multiple sclerosis).

Authors:  Rachel E Klaren; Robert W Motl; Jeffrey A Woods; Stephen D Miller
Journal:  J Neuroimmunol       Date:  2014-06-24       Impact factor: 3.478

Review 6.  Exercise therapy for fatigue in multiple sclerosis.

Authors:  Martin Heine; Ingrid van de Port; Marc B Rietberg; Erwin E H van Wegen; Gert Kwakkel
Journal:  Cochrane Database Syst Rev       Date:  2015-09-11

7.  Management of stress and stress-related diseases: Emerging computer-based technologies and the rationale for clinical laboratory assessment.

Authors:  Ezekiel Uba Nwose; Ross Stuart Richards
Journal:  N Am J Med Sci       Date:  2009-11

8.  Exercise in multiple sclerosis -- an integral component of disease management.

Authors:  Andrea Döring; Caspar F Pfueller; Friedemann Paul; Jan Dörr
Journal:  EPMA J       Date:  2011-12-24       Impact factor: 6.543

9.  Rehabilitation for people with multiple sclerosis: an overview of Cochrane Reviews.

Authors:  Bhasker Amatya; Fary Khan; Mary Galea
Journal:  Cochrane Database Syst Rev       Date:  2019-01-14

10.  Physical activity and the incidence of multiple sclerosis.

Authors:  Kirsten S Dorans; Jennifer Massa; Tanuja Chitnis; Alberto Ascherio; Kassandra L Munger
Journal:  Neurology       Date:  2016-09-28       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.